Artwork

Stephen Hays에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Stephen Hays 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

#82 - Eating Disorders - Prevalence, and Lack of Solutions with Courage Therapeutics Founder Dan Housman

42:53
 
공유
 

Manage episode 290666228 series 2583306
Stephen Hays에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Stephen Hays 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Today’s guest is Dan Housman. He’s the co-founder and CTO of Courage Therapeutics. We met Dan when he came through our first cohort of the What If Fellowship Program. His startup is a biopharma drug development business focused on eating disorders (anorexia nervosa specifically).

You can connect with Dan here: LinkedIn, Courage Therapeutics Website

Links mentioned in the show: NEDA, Feast, Daniel Le Grange Research

What If Fellowship Program: https://whatif.vc/

HERE ARE SOME THINGS WE TALKED ABOUT

  1. Dan tells us about the history of Courage Therapeutics and why his personal experience surrounding eating disorders inspired him to use his background in molecular biology to find a solution to this problem.
  2. We discuss the state of the market and current solutions available for eating disorders. Dan shares some of the reasons that he believes these current treatments only do so much.
  3. We discuss the drug that he has been working on developing, the effects that it is meant to have on those who struggle with anorexia, and Dan shares his hope that it can help to reduce the need for more severe treatment options.
  4. We talk about where Courage Therapeutics is at in the drug development timeline and what the next steps are to make sure that this drug will work and that it will be available as soon as safely possible.
  5. We discuss the statistics around eating disorders, specifically anorexia nervosa, and what this problem looks like in the United States, but also globally. Dan also shares that it’s not about how big the numbers are that necessarily make a product successful. There are many contributing factors.
  6. Dan shares about the stigma that surrounds eating disorders and why people are feeling unable to talk about them more.
  7. Dan shares resources for those who are interested in knowing more about eating disorders, who want to find resources to help themselves or a loved one who may be struggling with anorexia, and for general research papers around the topic itself.

Connect with the Stigma Podcast in the following ways: What If Fellowship, Patreon, Website, Twitter, Facebook, LinkedIn, Email

Connect with host Stephen Hays here: Stephen Hays Personal Website, Twitter, LinkedIn, What If Ventures (Mental Health Venture Fund)

  continue reading

91 에피소드

Artwork
icon공유
 
Manage episode 290666228 series 2583306
Stephen Hays에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Stephen Hays 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Today’s guest is Dan Housman. He’s the co-founder and CTO of Courage Therapeutics. We met Dan when he came through our first cohort of the What If Fellowship Program. His startup is a biopharma drug development business focused on eating disorders (anorexia nervosa specifically).

You can connect with Dan here: LinkedIn, Courage Therapeutics Website

Links mentioned in the show: NEDA, Feast, Daniel Le Grange Research

What If Fellowship Program: https://whatif.vc/

HERE ARE SOME THINGS WE TALKED ABOUT

  1. Dan tells us about the history of Courage Therapeutics and why his personal experience surrounding eating disorders inspired him to use his background in molecular biology to find a solution to this problem.
  2. We discuss the state of the market and current solutions available for eating disorders. Dan shares some of the reasons that he believes these current treatments only do so much.
  3. We discuss the drug that he has been working on developing, the effects that it is meant to have on those who struggle with anorexia, and Dan shares his hope that it can help to reduce the need for more severe treatment options.
  4. We talk about where Courage Therapeutics is at in the drug development timeline and what the next steps are to make sure that this drug will work and that it will be available as soon as safely possible.
  5. We discuss the statistics around eating disorders, specifically anorexia nervosa, and what this problem looks like in the United States, but also globally. Dan also shares that it’s not about how big the numbers are that necessarily make a product successful. There are many contributing factors.
  6. Dan shares about the stigma that surrounds eating disorders and why people are feeling unable to talk about them more.
  7. Dan shares resources for those who are interested in knowing more about eating disorders, who want to find resources to help themselves or a loved one who may be struggling with anorexia, and for general research papers around the topic itself.

Connect with the Stigma Podcast in the following ways: What If Fellowship, Patreon, Website, Twitter, Facebook, LinkedIn, Email

Connect with host Stephen Hays here: Stephen Hays Personal Website, Twitter, LinkedIn, What If Ventures (Mental Health Venture Fund)

  continue reading

91 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드